- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage II Multiple Myeloma in Spain
Total 289 results
-
BioLineRx, Ltd.Active, not recruitingMultiple MyelomaUnited States, Spain, Hungary, Germany, Italy
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
Hoffmann-La RocheRecruitingMultiple MyelomaBelgium, Korea, Republic of, Denmark, United Kingdom, Australia, New Zealand, Italy, Spain, France
-
Teva takedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, Belgium
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Notable LabsCompletedLymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmSpain, United States, Greece
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, France, China, Japan, Germany
-
CelgeneRecruitingMultiple MyelomaUnited States, France, Germany, Spain, United Kingdom, Italy
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
Janssen Research & Development, LLCCompleted
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Belgium, Germany, Spain, Portugal, Greece, Austria, Luxembourg
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Belgium, France, Germany, Italy, Japan, Spain
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNetherlands, Belgium, Germany, Spain, Czechia, Greece, Italy, Denmark, Serbia, Turkey
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
PETHEMA FoundationCelgene; Janssen-Cilag Ltd.; TFS Trial Form SupportCompleted
-
TakedaCompleted
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
-
AbbVieActive, not recruitingMultiple MyelomaUnited States, France, Germany, Italy, Japan, Spain
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Spain, Japan, Australia
-
AbbVieGenentech, Inc; Onyx Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States, Australia, Hungary, Puerto Rico, Spain
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
PETHEMA FoundationCompleted
-
CelgeneCompleted
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
TeneoOne Inc.RecruitingMultiple MyelomaIsrael, United States, Canada, Spain, France, Denmark, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Hoffmann-La RocheRecruitingMultiple MyelomaUnited States, Italy, Spain, Australia, Belgium, Israel, Germany, France
-
PETHEMA FoundationCompleted
-
Fundación Pública Andaluza para la gestión de la...Active, not recruitingMultiple Myeloma | Hematopoietic Stem Cell TransplantationSpain
-
TakedaActive, not recruitingMultiple MyelomaSpain, United States, Australia, China, Korea, Republic of, Canada, France
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
Novartis PharmaceuticalsActive, not recruitingMultiple MyelomaSaudi Arabia, Germany, Singapore, Italy, France, Israel, United Kingdom, Japan, Australia, Spain, Brazil, United States, Greece, Canada
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden